Free Trial

The Pennant Group (PNTG) Competitors

The Pennant Group logo
$32.04 -1.08 (-3.26%)
(As of 03:25 PM ET)

PNTG vs. USPH, SGRY, BTSG, GH, VCYT, LFST, CON, ARDT, ADUS, and PRVA

Should you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include U.S. Physical Therapy (USPH), Surgery Partners (SGRY), BrightSpring Health Services (BTSG), Guardant Health (GH), Veracyte (VCYT), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), Ardent Health Partners (ARDT), Addus HomeCare (ADUS), and Privia Health Group (PRVA). These companies are all part of the "medical" sector.

The Pennant Group vs.

U.S. Physical Therapy (NYSE:USPH) and The Pennant Group (NASDAQ:PNTG) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations, community ranking and profitability.

U.S. Physical Therapy has higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than U.S. Physical Therapy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
U.S. Physical Therapy$604.80M2.39$28.24M$1.0690.32
The Pennant Group$544.89M1.78$13.38M$0.6350.86

U.S. Physical Therapy received 212 more outperform votes than The Pennant Group when rated by MarketBeat users. Likewise, 56.15% of users gave U.S. Physical Therapy an outperform vote while only 46.43% of users gave The Pennant Group an outperform vote.

CompanyUnderperformOutperform
U.S. Physical TherapyOutperform Votes
251
56.15%
Underperform Votes
196
43.85%
The Pennant GroupOutperform Votes
39
46.43%
Underperform Votes
45
53.57%

85.9% of The Pennant Group shares are held by institutional investors. 1.7% of U.S. Physical Therapy shares are held by company insiders. Comparatively, 5.8% of The Pennant Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

U.S. Physical Therapy has a beta of 1.38, suggesting that its stock price is 38% more volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 2.02, suggesting that its stock price is 102% more volatile than the S&P 500.

In the previous week, U.S. Physical Therapy had 7 more articles in the media than The Pennant Group. MarketBeat recorded 16 mentions for U.S. Physical Therapy and 9 mentions for The Pennant Group. U.S. Physical Therapy's average media sentiment score of 0.88 beat The Pennant Group's score of 0.39 indicating that U.S. Physical Therapy is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
U.S. Physical Therapy
4 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
The Pennant Group
1 Very Positive mention(s)
0 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

U.S. Physical Therapy has a net margin of 4.06% compared to The Pennant Group's net margin of 3.16%. The Pennant Group's return on equity of 13.74% beat U.S. Physical Therapy's return on equity.

Company Net Margins Return on Equity Return on Assets
U.S. Physical Therapy4.06% 8.18% 3.92%
The Pennant Group 3.16%13.74%3.82%

U.S. Physical Therapy currently has a consensus target price of $105.00, suggesting a potential upside of 9.67%. The Pennant Group has a consensus target price of $37.50, suggesting a potential upside of 17.04%. Given The Pennant Group's stronger consensus rating and higher probable upside, analysts clearly believe The Pennant Group is more favorable than U.S. Physical Therapy.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
U.S. Physical Therapy
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

Summary

U.S. Physical Therapy beats The Pennant Group on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PNTG vs. The Competition

MetricThe Pennant GroupHealth services IndustryMedical SectorNASDAQ Exchange
Market Cap$971.13M$650.22M$5.27B$8.94B
Dividend YieldN/A2.13%5.10%4.03%
P/E Ratio50.8629.65123.3016.53
Price / Sales1.784.171,380.06106.39
Price / Cash41.3823.9338.9333.99
Price / Book6.593.104.925.36
Net Income$13.38M-$10.72M$118.11M$223.73M
7 Day Performance0.22%1.49%4.46%4.55%
1 Month Performance-1.63%9.46%10.28%7.36%
1 Year Performance174.55%373.52%37.44%28.10%

The Pennant Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PNTG
The Pennant Group
3.9424 of 5 stars
$32.04
-3.3%
$37.50
+17.0%
+182.6%$971.13M$544.89M50.865,791News Coverage
High Trading Volume
USPH
U.S. Physical Therapy
3.3746 of 5 stars
$81.38
+1.5%
N/A+14.1%$1.23B$604.80M76.776,720Dividend Announcement
Analyst Forecast
Analyst Revision
News Coverage
SGRY
Surgery Partners
2.6442 of 5 stars
$28.75
-0.2%
N/A+18.2%$3.65B$2.74B-106.4813,500Upcoming Earnings
Analyst Forecast
BTSG
BrightSpring Health Services
2.0907 of 5 stars
$17.25
+15.2%
N/AN/A$2.96B$8.83B0.0035,000Earnings Report
Analyst Forecast
Analyst Revision
News Coverage
High Trading Volume
GH
Guardant Health
4.6711 of 5 stars
$23.00
+5.1%
N/A-8.8%$2.83B$643.81M-5.621,779Analyst Forecast
News Coverage
Gap Up
VCYT
Veracyte
4.4269 of 5 stars
$34.31
+1.7%
N/A+54.4%$2.64B$361.05M-45.75790Earnings Report
Analyst Forecast
News Coverage
Gap Up
LFST
LifeStance Health Group
0.6738 of 5 stars
$6.81
+1.5%
N/A+21.5%$2.57B$1.06B-16.619,325News Coverage
Gap Up
Trading Halted
CON
Concentra Group Holdings Parent
N/A$20.08
-0.9%
N/AN/A$2.54B$1.84B0.0011,000Earnings Report
Dividend Announcement
Analyst Forecast
ARDT
Ardent Health Partners
N/A$17.70
+1.7%
N/AN/A$2.53B$5.63B0.0024,200Analyst Downgrade
News Coverage
Gap Down
ADUS
Addus HomeCare
4.8385 of 5 stars
$126.27
+1.5%
N/A+54.4%$2.29B$1.11B29.9234,846Earnings Report
Analyst Forecast
News Coverage
Gap Down
PRVA
Privia Health Group
3.0996 of 5 stars
$18.99
+3.4%
N/A-6.2%$2.20B$1.66B158.261,102News Coverage

Related Companies and Tools


This page (NASDAQ:PNTG) was last updated on 11/7/2024 by MarketBeat.com Staff
From Our Partners